S141: Eliciting anti-tumor t cell activity in chronic lymphocytic leukemia with bispecific antibody-based combination therapy
Résumé
Background: Identifying effective combination immunotherapy could offer hope to chronic lymphocytic leukemia (CLL) patients who relapse on previous lines of therapy. Although prior studies have described an exhausted and protumor T cell state, there may be potential to stimulate anti-CLL cytolytic T cell activity with novel therapy.
Domaines
Immunothérapie
Fichier principal
S141__ELICITING_ANTI_TUMOR_T_CELL_ACTIVITY_IN.42.pdf (173.42 Ko)
Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
